ArticleCureus2026
Relationship Between Depression, Anxiety, and Antihypertensive Medication Use Among Adults With Hypertension: A Descriptive Analysis Using the National Health and Nutrition Examination Survey (NHANES) 2013-2018.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHypertension continues to be a major public health burden, with poor blood pressure (BP) control often linked to inadequate antihypertensive medication use. Psychological factors such as depression and anxiety may further complicate treatment outcomes.
objectiveThe study aimed to examine the associations between depressive symptoms and anxiety-related symptoms with antihypertensive medication use and BP control among United States (U.S.) adults with hypertension.
methodsData from the National Health and Nutrition Examination Survey (NHANES) 2013-2018 were analyzed. Adults aged ≥18 years with diagnosed hypertension were included. Depressive symptoms were assessed using the nine-item Patient Health Questionnaire (PHQ-9). Anxiety symptoms were defined using NHANES mental health questionnaire items that assessed the frequency of feeling nervous, anxious, or unable to control worrying over the past two weeks. Antihypertensive medication use was defined as self-reported current use of prescription medication for high BP at the time of the NHANES interview, and BP control was determined using measured values. Survey-weighted logistic regression models were used to estimate adjusted ORs and 95% CIs. The unweighted analytic sample included 3,377 hypertensive adults after excluding participants with missing data on depression score and anxiety symptoms.
resultsAmong 46,509,348 hypertensive adults, 39,247,780 (84%) reported taking antihypertensive medication. Depression and anxiety were not significantly associated with antihypertensive medication use or BP control after full adjustment. However, antihypertensive medication use was strongly related to BP control (OR = 1.72, 95% CI: 1.25-2.35).
conclusionPsychological symptoms were not independently associated with antihypertensive medication use after adjustment for demographic and clinical factors, but consistent medication use significantly improved hypertension outcomes. Integrating behavioral and clinical strategies may strengthen hypertension management in the general population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.